Insider · CIK 0001375410
Jonathan Robert Hunt
Files at CATX (Perspective Therapeutics, Inc.). First filing Dec 19, 2023, latest Nov 17, 2025.
In brief
Jonathan Robert Hunt files SEC Form 4 as CFO at CATX (Perspective Therapeutics, Inc.). Since Dec 19, 2023, Jonathan Robert Hunt has reported 3 open-market buys worth $104k and 0 open-market sells worth $0, the latest filed on Nov 17, 2025.
A track record needs three past buys with six months of prices behind them; Jonathan Robert Hunt has 2, so none is measured yet.
The newest scored trade: bought $22k of CATX on Nov 13, 2025, filed Nov 17, 2025, scored 37 (weak). In the last 12 months: 1 buy worth $22k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CATX: Perspective Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Perspective Therapeutics, Inc. | $22k 11,000 shares | +23% | +21% from low-79% from high | |
| 50Moderate | Perspective Therapeutics, Inc. | $49k 12,829 shares | +36% | - | |
| 60Notable | Perspective Therapeutics, Inc. | $32k 125,000 shares | +65% | +24% from low-64% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Mar 4, 2026 |
| Nov 13, 2025 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +11,000 | $2.03 | $22k | 59,800 | Nov 17, 2025 |
| Mar 3, 2025 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Mar 5, 2025 |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +400 | $3.55 | $1,420 | 36,371 | Nov 27, 2024 |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +29 | $3.94 | $114 | 36,400 | Nov 27, 2024 |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +2,400 | $3.60 | $8,640 | 38,800 | Nov 27, 2024 |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +10,000 | $3.88 | $39k | 48,800 | Nov 27, 2024 |
| Dec 18, 2023 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +125,000 | $0.26 | $32k | 316,710 | Dec 19, 2023 |
| Dec 12, 2023 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock Options (right to buy)derivative | +1,248,776 | $0.00 | $0 | 2,527,429 | Dec 14, 2023 |
Questions about Jonathan Robert Hunt
Answered from the filings on this page, as of the latest one.
Is Jonathan Robert Hunt buying or selling?
In the last 12 months Jonathan Robert Hunt reported 1 open-market buy worth $22k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $22k of CATX on Nov 13, 2025. Grants, option exercises and tax withholding are not counted.
How did Jonathan Robert Hunt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Robert Hunt has 2.
Where does Jonathan Robert Hunt file Form 4?
Jonathan Robert Hunt has filed Form 4 at CATX (Perspective Therapeutics, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.